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Cell migration is an important feature of embryonic development as well as tumor metastasis. Border cells in the Drosophila ovary have
emerged as a useful in vivo model for uncovering the molecular mechanisms that control many aspects of cell migration including guidance. It
was previously shown that two receptor tyrosine kinases, epidermal growth factor receptor (EGFR) and PDGF- and VEGF-related receptor (PVR),
together contribute to border cell migration. Whereas the ligand for PVR, PVF1, is known to guide border cells, it is unclear which of the four
activating EGFR ligands function in this process. We developed an assay to detect the ability of secreted factors to reroute migrating border cells in
vivo and tested the activity of EGFR ligands compared to PVF1. Two ligands, Keren and Spitz, guided border cells whereas the other ligands,
Gurken and Vein, did not. In addition, only Keren and Spitz were expressed at the appropriate stage in the oocyte, the target of border cell
migration. Therefore, a complex combination of EGFR and PVR ligands together guide border cells to the oocyte.
© 2006 Elsevier Inc. All rights reserved.Keywords: Drosophila melanogaster; EGFR; PVF1; PVR; Vein; Spitz; Keren; Gurken; Border cells; MigrationIntroduction
Cell migrations contribute to proper embryonic develop-
ment, wound healing, immune system function, and tumor
metastasis. It can be a challenge to dissect the intricate
molecular mechanisms of cell migration in the context of the
whole organism. Border cells in the Drosophila ovary have
emerged as a useful model for studying the molecular
mechanisms that control cell migration in vivo, independent
of cell proliferation (Montell, 2003; Rørth, 2002). A number of⁎ Corresponding authors.
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doi:10.1016/j.ydbio.2006.04.438molecules have been identified that control when and where the
cells migrate, as well as which cells acquire the ability to move
and how the movement is coordinated with other events. In
addition, border cell migration has served as a genetic model for
identification of genes that contribute to the motility and
metastasis of ovarian carcinoma cells (Silver et al., 2004;
Yoshida et al., 2004).
Border cells are a specialized group of 6–10 follicle cells that
derive from an epithelium composed of about 900 cells
(Spradling, 1993) (Fig. 1A). The epithelium surrounds a
sixteen-cell syncytium composed of 15 support cells called
nurse cells and one oocyte located at the posterior end. The
nurse cells provide cytoplasm to the growing oocyte whereas
the follicle cells provide patterning signals and secrete the
eggshell. Border cells form a group at the anterior end of the egg
chamber and at stage 9 one of the cells extends a long process in
between the nurse cells (Fulga and Rorth, 2002). The border cell
cluster then detaches from the epithelium, migrates between the
nurse cells, and travels about 150 μm to the anterior border of
the oocyte. Subsequently, border cells move ∼10–15 μm
Fig. 1. Method used to test misguidance of border cells by secreted ligands. (A) Schematic of a wild-typeDrosophila ovariole showing egg chambers at stages 8 (S8), 9
(S9), and 10 (S10). Border cells (BCs, red) migrate between the nurse cells (NCs) until they reach the oocyte (yellow). Follicle cells (FCs) surrounding the oocyte are
indicated. (B) Stage 10 egg chamber with a GFP-marked clone of anterior follicle cells misexpressing PVF1 (green, arrowhead), in which border cells labeled for SN
(red, arrow) localize to the side of the egg chamber in association with ectopic PVF1; genotype is hs-FLP/+;+/UAS-PVF1;AyGAL4 17b (FLP-out GAL4), UAS-
mCD8::GFP/+. (C, D) Pattern of cb41-GAL4 expression in a stage 10 egg chamber (C) and an ovariole (D) as visualized with UAS-mCD8::GFP (UAS-mGFP; green),
a membrane-tethered GFP; actin (red in D) labels the cell cortex, DAPI (blue) labels nuclei, and SN (red in C) labels border cells (arrow). (C) Border cells do not
express cb41 at detectable levels. (D) cb41 is expressed in a mosaic pattern in all follicle cells, predominantly starting at stage 8. (E) Single optical section of a stage 9
egg chamber misexpressing two copies (2×) of the UAS-PVF1 transgene in anterior follicle cells (arrowheads) and stained for anti-PVF1 (red in E); genotype is UAS-
PVF1/+;UAS-PVF1/cb41-GAL4; the border cell cluster (arrow) is found adjacent to follicle cells expressing high levels of PVF1 (arrowheads). DAPI (cyan) labels
nuclei. (Inset) Merged optical z-sections of the same egg chamber showing the level of endogenous PVF1 in the oocyte. (F) Stage 10 egg chamber in which PVF1 is
misexpressed in anterior follicle cells. Actin (green) labels the cell cortex, DAPI (blue) labels nuclei, and SN (red) labels border cells (arrow). Border cells are found on
the side of the egg chamber, several nurse cells away from the anterior pole; same genotype as in panel E. Anterior is to the left in all panels.
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nucleus.
The anatomical simplicity of both the border cell migration
route and the tissue through which the cells migrate provide a
tractable system in which to characterize the precise contribu-
tions of individual guidance molecules. Two receptor tyrosine
kinases, the epidermal growth factor receptor (EGFR) and
PDGF- and VEGF-receptor related (PVR), have been implicat-
ed in border cell migration. PVR is the receptor for PDGF and
VEGF-related factor 1 (PVF1) (Duchek et al., 2001). PVR is
expressed in all follicle cells, whereas PVF1 is expressed in the
germline, and high levels of this protein accumulate in the
oocyte (Duchek et al., 2001). PVF1 and PVR have been shown
to function in border cell migration to the oocyte without
affecting cell fate specification, proliferation, or survival
(Duchek et al., 2001; McDonald et al., 2003). Definitive
evidence that PVF1 is a guidance factor is that PVF1 can
redirect border cells when it is ectopically expressed (McDonald
et al., 2003). Nevertheless, loss-of-function mutations in either
PVF1 or PVR lead to a relatively mild defect in border cell
migration, such that border cells stop short of the oocyte inabout 25% of mutant egg chambers. In addition, the migration
that does take place is properly guided (Duchek et al., 2001;
McDonald et al., 2003).
The mild nature of the migration defect in Pvf1 and Pvr
mutants indicates that additional factors contribute to border cell
migration. Like PVR, the Drosophila EGFR is expressed in
follicle cells (Sapir et al., 1998). Neither loss-of-function
mutations nor expression of a dominant-negative EGFR
impedes border cell migration to the oocyte (Duchek and
Rørth, 2001). However, co-expression of dominant-negative
PVR and dominant-negative EGFR leads to a more dramatic
migration defect than either one alone (Duchek et al., 2001),
although the migration that does occur is generally properly
guided. This result indicates that EGFR contributes to border
cell migration, but it is unknown if signaling through EGFR
contributes to steering the cells or more generally stimulates
motility. The most definitive way to distinguish between these
possibilities would be to test whether ectopic expression of
EGFR agonists can direct the cells to a new location in vivo.
The four activating ligands for the Drosophila EGFR are
Karen (KRN), whose expression has not been characterized, as
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expressed during oogenesis. VN, a neuregulin homolog, is a
weak activator of EGFR (Schnepp et al., 1998) and is only
expressed in dorsal follicle cells after border cell migration is
complete (Wasserman and Freeman, 1998); therefore, it is not a
good candidate for guiding these cells. GRK, a TGFα homolog,
is expressed in a tight crescent adjacent to the oocyte nucleus
(Neuman-Silberberg and Schupbach, 1993). SPI has been
reported to be expressed in all follicle cells throughout
oogenesis, although the level of expression is low and it is
not clear if the protein is processed and secreted from these cells
(Wasserman and Freeman, 1998). Germline expression has also
been observed but attributed to background staining (Wasser-
man and Freeman, 1998). KRN is a potent activating ligand for
EGFR, but no specific expression pattern for KRN has yet been
described and loss-of-function mutations have not been
reported (Reich and Shilo, 2002; Urban et al., 2002).
We have developed an assay to detect the ability of secreted
proteins to influence the direction of border cell migration and
used it to determine if any of the EGFR ligands was capable of
redirecting border cell migration when ectopically expressed.
This assay takes advantage of the temperature-sensitive (ts)-
GAL80 repressor to suppress the early lethality that results
when active EGFR ligands are expressed using the GAL4/UAS
system. Ectopic expression of a secreted form of KRN or SPI,
like PVF1, was able to redirect border cell migration, and
together their effects were additive. In contrast, GRK and VN
were ineffective. Moreover Krn and spi mRNAs were detected
by in situ hybridization throughout the oocyte at the time of
border cell migration. Finally, a combination of loss-of-function
analyses suggests functional redundancy of EGFR ligands.
Taken together, these findings indicate that SPI and KRN likely
function together with PVF1 to guide border cells.
Materials and methods
Drosophila strains and genetics
Krn loss-of-function mutants were generated using the P-element lines
KG05557 and KG00294. KG05557 is inserted 22 base pairs upstream of the
first exon of the Krn gene (CG32179) and KG00294 is inserted 47 base pairs
from the 5′ end of the first exon of the Protein on ecdysone puffs (Pep) gene. To
generate the two independent Krn deletion alleles, we generated flies that were
transheterozygous for KG05557 and KG00294, then excised the P-elements
using standard methods. Viable lines lacking w+ eyes were kept and the
breakpoints were determined by sequencing PCR products from these lines.
Krn27-7-B removes the entire Krn gene, from the 5-prime UTR of Krn up to and
including 100 base pairs of the first exon of the adjacent gene Pep (the first ATG
of Pep is in exon 2). Krn9-6-A removes the intron of Krn and all of exon 2, which
contains the first ATG for Krn, up to and including 100 base pairs of exon 1 of
Pep, but does not include the noncoding exon 1 of Krn.
The following strains were used in this study: w1118 strain for wild-type
analysis, UAS-mCD8∷GFP (Lee and Luo, 1999), UAS-PVF1 (McDonald et al.,
2003), UAS-GRKΔTC (UAS-s-GRK) (Queenan et al., 1999), UAS-VN
(Schnepp et al., 1998), UAS-s-SPI (Schweitzer et al., 1995), UAS-s-KRN
(Urban et al., 2002), UAS-PVF2 (Cho et al., 2002); tub-GAL80ts 20 (McGuire et
al., 2003), UAS-VN mutant chimeras (Donaldson et al., 2004), UAS-DN-EGFR
(Bloomington Stock Center), and UAS-DN-PVR (Duchek et al., 2001). We used
the loss-of-function alleles Pvf11624 (Duchek et al., 2001) and spi2A14; for details
on these alleles, see Flybase (http://www.flybase.bio.indiana.edu). The following
GAL4 lines were used: slbo-GAL4 (Rørth et al., 1998), cb41-GAL4 (Ward et al.,2002), and AyGAL4 17b (‘FLP-out' GAL4) (Ito et al., 1997). The UAS-s-KRN
transgene inserted on the second chromosome was generated essentially as
described (Reich and Shilo, 2002; Urban et al., 2002). Standard Drosophila
genetic techniques (Greenspan, 1997) were used to generate lines containing
multiple transgenes as well as the tub-GAL80ts 20;cb41-GAL4 line (ts-GAL80;
cb41-GAL4), which was crossed to various UAS lines (see below).
We used the FLP/FRT system (Xu and Rubin, 1993) to generate spi mutant
germline clones in a Pvf1 mutant background. hs-FLP, Pvf11624; ubiquitin-
nuclear-GFP, FRT40A flies were crossed to Pvf11624;spi2A14, FRT40A or Pvf11624;
grkHF, spi2A14, FRT40A flies. Embryos were laid for 1 day and larvae were heat
shocked at the 2nd and 3rd instar stages. Ovaries were dissected from adult
females and phenotypes analyzed in egg chambers lacking GFP in the germline,
indicating that germline clones were made.
Ectopic expression
Experiments using ‘FLP-out’ GAL4 (AyGAL4) (Ito et al., 1997) were
performed as described (McDonald et al., 2003), except that clones were marked
by UAS-mCD8∷GFP. cb41-GAL4 was used to misexpress UAS-Pvf1, UAS-s-
GRK, and UAS-VN in follicle cells of the ovary. Crosses were performed at
25°C and females were incubated overnight at 29–30°C before ovaries were
dissected and analyzed. For UAS transgenes that were lethal in combination
with cb41-GAL4, we used the ts-GAL80; cb41-GAL4 line to repress transgene
expression until the lethal phase was completed. Crosses were performed at
18°C until adult flies eclosed. Adult females were shifted to 30–31°C for 13–
24 h before dissection to express the UAS transgenes. Border cell misguidance
was assayed essentially as described (McDonald et al., 2003). Briefly, border
cells were identified as having a misguided phenotype if they were observed off
their normal migration pathway, generally on the side of the egg chamber.
Ectopic expression of UAS lines with slbo-GAL4 was done at 30°C for 13–24 h.
Antibody staining and in situ hybridization
Ovary dissection was performed as described (Bai et al., 2000). Ovaries
were either left whole (for anti-SN staining) or dissected further into ovarioles,
fixed for 10 min in 4% methanol-free formaldehyde/0.1 M potassium phosphate
buffer, pH 7.4, washed three times for 30 min in NP40 block (50 mM Tris–HCl,
pH 7.4, 150 mMNaCl, 0.5%NP40, 5 mg/mL BSA), and incubated with primary
antibody in NP40 block overnight. Ovaries were washed several times with
NP40 block for 2 h, incubated with secondary antibody for 2 h, washed with
NP40 block overnight (for anti-SN antibody) or for 2 h, and mounted in
Vectashield (Vector Laboratories). All incubations were performed at room
temperature except primary antibody incubation, which was performed at 4°C.
We used the following primary antibodies at the indicated dilutions: mouse anti-
SN monoclonal (7C; 1:25) (Cant et al., 1994); rat anti-PVF1 serum (1:100)
(Rosin et al., 2004); rabbit anti-GFP serum (1:2000; Molecular Probes); mouse
anti-GRK monoclonal (1D12; 1:10) (Queenan et al., 1999). Secondary
antibodies conjugated to Alexa Fluor 488 or Alexa Fluor 568 were used at
1:400 dilution. Alexa 488-phalloidin or Alexa 568-phalloidin was added during
secondary incubation at 1:1200 dilution. DNA was visualized with DAPI
(0.5 μg) added during secondary incubation. Images were acquired on a Zeiss
Axioplan 2 imaging microscope using the ApoTome system with a Zeiss
Axiocam MRM CCD camera and AxioVision 4 software. Figures were
assembled using Adobe Photoshop.
In situ hybridization was performed as described with minor modifications
(Silver and Montell, 2001). Digoxigenin-labeled antisense and sense RNA
probes were generated corresponding to the full-length region of Krn from the
Krn EST LD 34470 (a gift from B. Shilo), the full-length region of spi
(DrosophilaGene Collection clone from Open Biosystems, clone ID RH69567),
and Vn-1 (as described in Schnepp et al., 1996). Hybridizations were performed
at 65°C. A detailed protocol is available upon request.Results
GRK (Duchek et al., 2001; Rørth, 2002; Shilo, 2003) and
VN (Dormann and Weijer, 2003) have each been suggested to
Table 1
Quantification of border cell misguidance following misexpression of ligands in
follicle cells
Genotype a (n) b % Misguidance c
UAS-PVF1 (1×) d (191) 42
UAS-PVF1 (2×) (120) 93
UAS-s-GRK (2×) (200) 0
UAS-s-GRK (3×) (208) 0
UAS-VN (1×) (220) 0
UAS-VN (2×) (290) 0
UAS-s-SPI (1×) (338) 28
UAS-s-KRNe (1×) (187) 27
UAS-s-KRN f (1×) (373) 8
UAS-s-KRN (2×) (227) 33
UAS-s-SPI;UAS-s-KRNe (205) 53
UAS-s-KRNe;UAS-s-GRK (88) 24
UAS-PVF2 (1×) (203) 0
a Genotypes are ts-GAL80/+; cb41-GAL4/UAS-x, where x is the indicated
transgene.
b Total number of egg chambers examined for each genotype.
c See text for description of misguidance phenotype.
d Number of transgenes expressed.
e Insert on chromosome II.
f Insert on chromosome III.
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border cells to the oocyte. However, unlike PVF1, neither factor
is expressed throughout the oocyte during stage 9, and although
GRK is required for the dorsal turn that border cells make once
they reach the oocyte, grk mutant egg chambers exhibit normalFig. 2. Effect of secreted ligands misexpressed in anterior follicle cells on border cel
cortex (green), DAPI to visualize DNA (blue in C–F), and SN (red in C–F) to visualiz
is the indicated transgene). (A, B) Stage 9 (A) and stage 10 (B) egg chambers misexpre
Endogenous GRK localizes to the dorsal–anterior corner of the oocyte (arrow). Bord
cells (arrowheads). (C–F) Stage 10 egg chambers misexpressing UAS-VN (C), UAS
both UAS-s-SPI and UAS-s-KRN. (C) Border cell migration is normal when UAS-V
normal migration pathway on the side of the egg chamber when s-SPI (D), s-KRN (E)
to the left in all panels.migration of border cells to the anterior border of the oocyte
(Duchek and Rørth, 2001). Therefore, we decided to investigate
which of the known activating ligands for the EGFR were most
likely to participate in this process. First, to determine if any of
the EGFR ligands was capable of guiding border cells in vivo,
we set out to test the ability of a secreted form of each protein to
redirect border cells following misexpression in anterior follicle
cells. We have previously shown that misexpression of PVF1,
but not secreted GRK (s-GRK), was capable of redirecting
border cells towards anterior follicle cells using the FLP-out
GAL4 system (Fig. 1B) (McDonald et al., 2003). However,
secreted KRN (s-KRN) and secreted SPI (s-SPI) caused a cell
lethal phenotype in this assay. We then obtained a GAL4 line,
cb41 (Ward et al., 2002), which induced expression of UAS
transgenes in a mosaic pattern within the follicle cells that
included anterior cells but did not include border cells (Figs.
1C–E). UAS-PVF1 was expressed well using the cb41-GAL4
driver (Fig. 1E) and misguided border cells efficiently (Fig. 1F;
Table 1).
We tested the ability of each of the EGFR ligands to redirect
border cells following misexpression in anterior follicle cells
using cb41. Whereas VN is synthesized as a secreted protein,
SPI, KRN, and GRK are synthesized as transmembrane
precursor proteins that require additional proteins, Star and
Rhomboid, for transport and processing to an active, secreted
form (Urban et al., 2002). To circumvent the need for
processing, we expressed truncated forms of these proteins,
which are constitutively secreted, under the control of UASl migration. Egg chambers are stained for phalloidin to visualize actin at the cell
e border cells (arrows); genotypes are ts-GAL80/+;cb41-GAL4/UAS-x (where x
ssing three copies (3×) of the UAS-s-GRK transgene stained for anti-GRK (red).
er cells (arrow, bc) migrate normally when UAS-s-GRK is expressed in follicle
-s-SPI (D), two copies (2×) of the UAS-s-KRN transgene (E), or co-expressing
N is expressed in anterior follicle cells. (D–F) Border cells are found off their
, and both s-SPI and s-KRN together (F) are expressed in follicle cells. Anterior is
Fig. 3. Quantification of migration defects caused by overexpression of secreted
ligands in border cells. Border cell migration is shown as the proportion of stage
10 egg chambers in which border cells migrated 0–25% (yellow), 26–50%
(blue), 51–75% (red), and 76–100% (black) of the normal distance. The number
of egg chambers examined for each genotype is indicated (n). Genotypes are
slbo-GAL4,UAS-mCD8::GFP/UAS-x (where x is the indicated transgene);
experiments were performed at least twice at 30°C. Inset, egg chamber showing
a representation of the distance border cells migrate towards the oocyte; anterior
is at the top.
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et al., 2002). In some cases, multiple transgenes were combined
in order to increase the level of misexpressed protein. Neither s-
GRK nor VN was able to redirect border cells when expressed
with cb41, even when multiple transgenes were used (Figs. 2A–
C; Table 1). The level of ectopically expressed GRK protein
appeared to exceed that of the endogenous protein, especially
considering that the ectopically expressed protein was produced
in closer proximity to the migrating border cells than the
endogenous GRK protein (Figs. 2A and B).
We next tested the ability of s-SPI and s-KRN to misguide
border cells with cb41. Both s-SPI and s-KRN caused lethality
in combination with cb41, presumably due to the deleterious
effects of earlier expression of these potent factors during
development. To circumvent this problem, we combined a
transgene expressing a temperature-sensitive form of the
GAL4-specific transcriptional repressor GAL80 (McGuire et
al., 2003, 2004) with cb41-GAL4 and either s-SPI or s-KRN.
These flies were allowed to develop at 18°C, so that the Gal80
repressor was active and expression of s-SPI or s-KRN was
inhibited allowing adult flies to eclose. The adults were then
shifted to 30°C, inactivating the repressor and allowing GAL4-
driven expression of s-SPI or s-KRN. Dissection and staining of
ovaries from these flies demonstrated that both s-SPI and s-
KRN were capable of misguiding border cells (Figs. 2D and E;
Table 1).
As with PVF1, increasing the number of UAS-s-KRN
transgenes, and therefore presumably increasing the concentra-
tion of misexpressed protein, increased the percentage of egg
chambers in which border cells were misguided (Table 1).
Different UAS-s-KRN transgene insertions had different levels
of activity in this assay. The insertion on the second
chromosome caused misrouting of border cells in 27% of egg
chambers whereas the insertion on the third chromosome
caused misrouting in only 8% of egg chambers. It is likely that
these differences are due to different expression levels of
protein-driven by the different transgenes. Expression of s-SPI
and s-KRN together was more effective at misguiding border
cells than either transgene alone and the effect was approxi-
mately additive rather than synergistic (Fig. 2F; Table 1).
Misexpression of both s-GRK and s-KRN was similar to
misexpression of s-KRN alone (Table 1).
The inability of VN or s-GRK to redirect border cell
migration was not due to a lack of biological activity of the
proteins synthesized in follicle cells because all of the ligands
inhibited border cell migration when expressed autonomously in
the cluster using slbo-GAL4 (Fig. 3). Expression of two copies
of PVF1, one copy of s-SPI, or one copy of s-KRN caused a
strong migration defect, whereas expression of two or three
copies of s-GRK or two copies of VN caused amilder but readily
detectable migration defect (Fig. 3). In addition, we expressed
the ligands in the wing and in follicle cells and observed
phenotypes consistent with activation of EGFR (Supplemental
Table 1; data not shown). Therefore, all of the EGFR ligands can
disrupt border cell migration when overexpressed in these cells,
consistent with a previous report (Duchek and Rørth, 2001). To
investigate the mechanism underlying the observed ligandspecificity, we tested several chimeric and truncated forms of
VN for their ability to reroute border cells. The normal VN
protein contains several distinct domains, including a signal
peptide, a PEST sequence, a central MR domain, a single Ig
domain, and an EGF domain, which are diagrammed in Fig. 4A
(Donaldson et al., 2004). Previous studies have shown that
replacement of the VN-EGF domain with that of Spitz increases
its potency (Schnepp et al., 1998). Consistent with that result, we
found that expression of the VN∷SPI-EGF chimera rerouted
border cells efficiently (Fig. 4B). Previous studies have also
indicated that deletion of a portion of the central MR domain
increases the biological activity of VN (Donaldson et al., 2004).
Likewise, we found that VN∷ΔMR was very active in the
border cell misguidance assay (Fig. 4B). Thus, it appears that
multiple domains within the VN amino acid sequence function
to reduce its potency in guiding border cells, as is true for its
other biological effects. However, deletion of the N-terminal
PEST sequence did not confer any activity in the border cell
guidance assay (Fig. 4B), whereas in the wing this protein is
Fig. 4. Effect on border cell migration by misexpression of Vn chimeric and
mutant transgenes in anterior follicle cells. (A) Schematic of VN protein
showing the signal peptide (SP), PEST degradation, middle region (MR), Ig, and
EGF domains. Amino acid positions are indicated below the schematic (adapted
from Donaldson et al., 2004; Schnepp et al., 1996). (B) Misguidance of border
cells by the indicated VN transgenes. Genotypes are ts-GAL80/+;cb41-GAL4/
UAS-x, where x is the indicated transgene. At least two experiments were
performed for each genotype. Data for UAS-VN full length (FL; 2×) are from
Table 1 and shown for comparison. Two different inserts were examined for
UAS-VN::SPI-EGF (on the 2nd or 3rd chromosomes) and UAS-VN:ΔPEST
(on the X or 3rd chromosomes). The number of egg chambers examined for each
genotype is indicated (n).
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confirmed that VNΔPEST and the other UAS-VN mutant
transgenes were capable of activating EGFR in the wing and
eggshell by expressing the UAS transgenes with GAL4 drivers
expressed in the pupal wing and in follicle cells, respectively
(Supplemental Table 1; data not shown). Thus, there may be
tissue specificity with respect to the importance of PEST-
mediated proteolytic degradation of VN.
To evaluate which endogenous EGFR ligands were most
likely to participate in guiding border cells to the oocyte, we
investigated the expression of each one by in situ hybridization.
Specific hybridization of the Krn antisense probe was observed
in the oocyte at late stage 8 and throughout stage 9, when border
cells migrate (Figs. 5A–C). This is very similar to the pattern of
PVF1 protein expression (Duchek et al., 2001) (Fig. 1E). This
expression pattern was specific because it was not detected in
ovaries from females homozygous for a deletion mutation that
removed the entire Krn open reading frame (Figs. 5D and E),
which was induced by imprecise excision of two P-elements,
one inserted into the Krn 5′UTR and the other inserted in the
first exon of the adjacent gene Pep (Fig. 5J). An antisense spi
probe generated from the full-length spi cDNA also resulted in
specific labeling throughout the oocyte at stages 8 and 9 (Figs.
5F–H). We then confirmed the previously published expression
patterns for grk and Vn. Vn was expressed in dorsal follicle cells
at stage 10, as previously reported (Fig. 5I), whereas specific
staining was not observed at stage 9 (Wasserman and Freeman,1998). GRK mRNA and protein (Figs. 2A and B) were
expressed in a dorsal/anterior crescent in the oocyte as expected
(Neuman-Silberberg and Schupbach, 1993, 1996). Therefore,
Krn and spi localize specifically to the oocyte at stages 8 and 9
when border cells migrate to the oocyte, whereas Vn does not
and grk is expressed asymmetrically in the oocyte.
Loss-of-function phenotypic analysis of the EGFR ligands is
complicated by their functional redundancy with Pvf1. After
generating Krn loss-of-function mutants as diagrammed in Fig.
5, we found that Krn homozygous mutant flies were viable and
fertile and exhibited normal border cell migration (Table 2). Egfr
mutants on their own do not exhibit defective migration of
border cells from the anterior tip of the egg chamber to the
anterior border of the oocyte (Duchek and Rørth, 2001; Duchek
et al., 2001) (Table 2); therefore, we did not examine spi mutant
germline clones, either alone or in aKrnmutant background. It is
already known that border cell migration to the oocyte is normal
in grk mutant egg chambers (Duchek and Rørth, 2001). Strong
migration defects are only seen in when dominant-negative
versions of EGFR and PVR receptors are co-expressed (Duchek
et al., 2001; Jekely et al., 2005) (Table 2). Thus, the relevant
EGFR ligand should exhibit comparable migration defects when
doubly mutant with Pvf1. Double mutants for Pvf1 andKrnwere
indistinguishable from Pvf1 single mutants (Table 2). Likewise,
border cell migration in egg chambers containing spi mutant
germline clones in a Pvf1 homozygous mutant background was
indistinguishable from Pvf1 alone (Table 2). We attempted to
generate spi mutant germline clones in a Pvf1;Krn double
mutant background; however, the intermediate genotypes were
poorly viable or sterile and therefore this experiment was not
feasible (Table 2). Taken together, these results suggest
functional redundancy among ligands for the EGFR, in addition
to functional redundancy between EGFR and PVR.
Discussion
In general, it is clear that a variety of chemoattractants and
chemorepellents activate cell surface receptors to steer migrat-
ing cells. However, many of the same factors that guide cells in
vitro are required in vivo for cell fate specification, survival,
and/or proliferation (reviewed in Bottcher and Niehrs, 2005;
Buonanno and Fischbach, 2001; Coumoul and Deng, 2003;
Hoch and Soriano, 2003). This can make it difficult to separate
the contribution of a particular factor to guidance independent
of its other functions. Most studies implicating vertebrate EGFR
ligands in chemotaxis have been performed in cell culture and
the role of these ligands in guiding cells in vivo remains to be
tested. Therefore, we developed an assay to test the ability of
secreted proteins to guide border cells in vivo.
The studies reported here represent the first demonstration
that ectopic expression of ligands for the Drosophila EGFR can
redirect migratory cells in vivo. The ability of s-SPI and s-KRN
to reroute border cells, together with the endogenous expression
of spi and Krn mRNA in the oocyte and the strong border cell
migration phenotype following reduction of both EGFR and
PVR signaling, indicate that signaling through EGFR normally
contributes to guiding border cells to the oocyte. VN is unlikely
Fig. 5. Expression of Krn, spi, and Vn in egg chambers during mid-oogenesis. (A–C)Wild-type (WT) stage 8 (A) and stage 9 (B, C) egg chambers hybridized with Krn
antisense probe (A, B) or sense probe (C). Krn is expressed primarily in the oocyte, whereas no specific expression is observed with sense probe. (D, E) Krn27-7-B
homozygous mutant egg chambers at stage 8 (D) and stage 9 (E) hybridized with Krn antisense probe. Krn expression is lost in Krnmutant egg chambers. No specific
staining was observed with sense probe in Krn mutant egg chambers (not shown). (F–H) Stage 8 (F) and stage 9 (G, H) egg chambers hybridized with spi antisense
probe (F, G) or spi sense probe (H). spi is expressed primarily in the oocyte, whereas no specific expression is observed with sense probes. (I) Stage 10B egg chamber
hybridized with Vn antisense probe. Vn is expressed in dorsal–anterior follicle cells primarily beginning at stage 10B (Wasserman and Freeman, 1998). Anterior is to
the left in all panels. (J) Map of the Krn locus. The P-element KG05557 is inserted 22 base pairs upstream of exon 1. The Krn translation start site (arrowhead, ATG)
and stop codon (arrow, TAA) are in exon 2. The breakpoints for the Krn alleles Krn9-6-A and Krn27-7-B are indicated. The adjacent gene, Pep, is shown (see Materials
and methods). KG00294 is inserted in the first exon of Pep. CG32177 (exon 3 of Krn) shares the same 5′ exon (exon 1) as Krn.
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misguidance assay and endogenous expression is not detected
in the germline. The question then arises as to whether GRK
contributes to guiding border cells. It seems unlikely to
contribute significantly to their posterior migration because it
is ineffective in the misguidance assay, even when the ectopic
expression equals or exceeds the endogenous expression and
the ectopic expression is closer to border cells. Furthermore,
GRK protein is highly localized in a dorsal/anterior crescent
within the oocyte, whereas there is no discernable dorsal bias to
the path that border cells take to the oocyte, even in the absence
of Pvf1 (McDonald et al., 2003).
There are a variety of possible explanations for this
specificity. In other biological assays, VN appears to function
as a weaker agonist than the other ligands (Schnepp et al.,
1998). Whereas GRK has not been suggested previously to be
a lower affinity agonist than SPI or KRN, this may
nevertheless be the case. One manifestation of its low affinitymay be the observation that its effects are only observed in
very close proximity to its site of synthesis. Another
possibility is that GRK is produced and released in such a
way as to act only locally without having a lower affinity. Its
established function in specifying dorsal follicle cell fate
would not require action over a long distance, and it may not
need to be a high affinity agonist because it also induces
expression of VN in the overlying follicle cells. In fact, action
at a distance would be detrimental because the activity needs
to be restricted, first to posterior follicle cells and then to
dorsal cells. In addition, the demonstrated role of GRK in the
short dorsal movement that border cells make once they reach
the oocyte (Duchek and Rørth, 2001) would also require only
short-range action. Whether this is simply a reflection of
differences in affinity or whether this is also a consequence of
a more specific mechanism for regulating the distance at
which these factors can exert their effects remains to be
investigated.
Table 2
Quantification of border cell migration defects following loss of EGFR ligands
Genotype (n) a % Border cell
migration defect b
Krn27-7-B / Krn27-7-B (≥100) 0
Krn9-6-A / Krn9-6-A (≥100) 0
Pvf11624 / Pvf11624; Krn27-7-B / Krn27-7-B (541) 13
Pvf11624 / Pvf11624 (1211) 13
Pvf11624 / Pvf11624; spi2A14 / spi2A14 (118) c 9
Pvf11624 / Pvf11624; spi2A14 / + (659) 7
Pvf11624 / Pvf11624; grkHF, spi2A14 / grkHF, spi2A14 (12) c NDd
Pvf11624 / Pvf11624; spi2A14 / spi2A14; Krn27-7-B / Krn27-7-B ND
slbo-GAL4/UAS-DN-EGFR 0
slbo-GAL4/UAS-DN-PVR 16
slbo-GAL4,UAS-DN-PVR/UAS-DN-EGFR 90
DN, dominant negative; ND, could not be determined.
a Total number of stage 10 egg chambers examined for each genotype.
b Percentage of border cells that did not complete their migration to the
oocyte by stage 10.
c Egg chambers in which all germline cells were homozygous mutant for
Pvf1 and spi.
d Egg chambers did not develop normally.
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migration when expressed in border cells with slbo-GAL4
(Duchek and Rørth, 2001; Duchek et al., 2001; McDonald et
al., 2003) (this study). The potency of this effect is
proportional to their potency in redirecting border cell
migration such that the effect of expressing VN or s-GRK is
far weaker than the effect of s-SPI, s-KRN, or PVF1. This
effect confirms that the cells are capable of responding to the
ligands even when they are expressed by follicle cells, and
indicates that the ability to misguide border cells is a more
stringent test for activity than the ability to impede migration
when misexpressed in border cells. A second PVF homolog,
PVF2, is ineffective in both assays (Table 1 and Fig. 3)
(McDonald et al., 2003), suggesting that border cells are not
responsive to this ligand. This is not due to a problem with the
UAS-PVF2 transgene because hemocytes in the Drosophila
embryo are able to respond to ectopically expressed PVF2 but
not PVF1 (Cho et al., 2002).
The expression of Krn in the oocyte is the first identified in
vivo expression for Krn in the fly. Krn was identified in the
genome sequence by homology with other ligands for the
EGFR. Biochemical studies confirm its ability to activate EGFR
(Reich and Shilo, 2002; Urban et al., 2002). Misexpression
studies show that it possesses the same biological activities as
SPI (Reich and Shilo, 2002; Urban et al., 2002) and our results
agree. spi is expressed in a variety of cell types throughout
development (Rutledge et al., 1992; Tio et al., 1994; Wasserman
and Freeman, 1998), whereas Krn is either expressed in fewer
cell types or expressed at a level that is below the level of
detection with current methods (Reich and Shilo, 2002; Urban
et al., 2002), with the exception of the expression in the oocyte
reported here.
spi, like Krn, is expressed in the oocyte, although this
expression has not previously been reported. Wasserman and
Freeman (1998) investigated spi expression and function
during oogenesis in the context of studying EGFR signalingin dorsal follicle cell fate specification. They reported that spi
was expressed in all follicle cells, albeit at a low level. They
also observed strong labeling of the germline; however, they
attributed this to background staining because it was present in
spi mutant germline clones. Although it is reasonable to
conclude that the staining they observed was not specific to spi,
the high background staining did not allow any conclusion to
be drawn concerning whether or not spi was actually expressed
in the germline. When we used a probe for the full-length spi
cDNA we observed specific staining in the oocyte, rather than
the uniform staining throughout the nurse cell-oocyte complex
that Wasserman and Freeman (1998) observed. spi is strongly
expressed in the early embryo (Rutledge et al., 1992) most
likely because of maternal contribution of spi, which is
consistent with the expression we observe in the oocyte. We
did not detect staining with a sense probe and thus conclude
that this labeling is specific. Our results indicate that spi
appears to be expressed at a higher level in the oocyte than
Krn, although the in situ hybridization technique is not
quantitative.
The observed expression of spi and Krn mRNAs in the
oocyte raises the important question as to how EGFR is not
uniformly activated in all follicle cells. Uniform activation
would be a problem because patterned EGFR signaling
contributes to specifying both posterior and dorsal follicle cell
fates (Gonzalez-Reyes and St Johnston, 1998; Gonzalez-Reyes
et al., 1995; Roth et al., 1995; Wasserman and Freeman, 1998).
It is likely that posterior and dorsal follicle cells still receive a
higher overall level of EGFR activation compared to other
follicle cells even though these populations may be exposed to
similar levels of SPI and KRN. Both posterior and dorsal
follicle cells are in proximity to high local concentrations of
GRK and VN is expressed in response to GRK signaling,
resulting in a further amplification of EGFR in the two dorsal
follicle cell populations (Wasserman and Freeman, 1998).
Further evidence that all follicle cells require some EGFR
signaling is that EGFR null follicle cell clones are small and
infrequent (James et al., 2002) (J.A.M., unpublished). This
suggests that at least early in oogenesis EGFR signaling
contributes to follicle cell survival. It is also possible that most
follicle cells express a negative regulator of EGFR signaling
that attenuates the signal in the appropriate pattern.
We propose that KRN functions redundantly with SPI and
that together they are redundant with PVF1 in guiding border
cells to the oocyte. Loss-of-function mutations in spi cause
many developmental defects (reviewed in Shilo, 2003). In
contrast, flies lacking Krn are viable and fertile as reported here,
indicating that Krnmay function redundantly with other growth
factors. The ultimate test of this hypothesis will be to generate
double and triple mutant flies, which has so far been
impractical.
The simplicity of the border cell migration path belies the
molecular complexity that controls their guidance. Whereas
functional redundancy among guidance cues that control axon
pathfinding might be attributed to the extreme anatomical
complexity of the nervous system, the work described here
demonstrates that even anatomically very simple migrations can
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This study, as well as others (Duchek and Rørth, 2001; Duchek
et al., 2001; McDonald et al., 2003), indicate that signaling by
both the PVR and EGFR pathways guide border cells.
Additional cues may contribute to this process because border
cells expressing both dominant-negative PVR and dominant-
negative EGFR still show significant evidence of correctly
guided migration. The majority of border cells deficient for both
PVR and EGFR migrate between 25% and 75% of the way
towards the oocyte and they almost always choose the correct
path (Duchek et al., 2001; Jekely et al., 2005). In addition, about
10% of border cells still reach the oocyte (Table 2). Further
studies will be required to reveal the identity of any additional
ligands and receptors that play a role in this process.
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